Platts-Mills T A
Division of Allergy and Immunology, University of Virginia, Charlottesville, Virginia, USA.
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 2):S1-5. doi: 10.1164/ajrccm.164.supplement_1.2103024.
It has been nearly a century since the first suggestion that a soluble factor in plasma or serum might be responsible for the symptoms of allergic disease and asthma, and more than 30 yr since immunoglobulin E (IgE) was identified as the key molecule in mediating what are now described as type 1 hypersensitivity reactions (allergic asthma, allergic rhinitis, food allergy, atopic dermatitis, some forms of drug allergy, and insect sting allergy). Since that time, many of the details of the inflammatory cascade underlying allergy and asthma have been elucidated, and IgE is now known to play a key upstream role. The goals of this report are to review the cellular and molecular events set in motion by IgE and to examine the evidence for its participation in both the immediate allergic response and the late-phase or chronic inflammatory response in the skin and lungs.
首次提出血浆或血清中的可溶性因子可能是过敏性疾病和哮喘症状的病因,至今已近一个世纪;而免疫球蛋白E(IgE)被确定为介导现在所说的1型超敏反应(过敏性哮喘、过敏性鼻炎、食物过敏、特应性皮炎、某些形式的药物过敏和昆虫叮咬过敏)的关键分子,则已有30多年。从那时起,过敏和哮喘潜在的炎症级联反应的许多细节已得到阐明,现在已知IgE发挥关键的上游作用。本报告的目的是回顾由IgE引发的细胞和分子事件,并审视其参与皮肤和肺部即时过敏反应以及迟发性或慢性炎症反应的证据。